7 completed, 4 not yet recruiting, 3 recruiting, 1 enrolling by invitation. 15 Phase 2, 2 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 15 | Completed 7, Not yet recruiting 4, Recruiting 3, Enrolling by invitation 1 |
| Phase 3 | 2 | Completed 1, Recruiting 1 |
| Phase 1 | 1 | Recruiting 1 |
Follow Posttraumatic Stress Disorder (PTSD): new trials by email Literature Review of Posttraumatic Stress Disorder (PTSD) trials Research Report on Posttraumatic Stress Disorder (PTSD)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Enhancing the Effect of Stellate Ganglion Block in the Treatment of PTSD: Bupivacaine vs Bupivacaine + Ketamine SGB - Combined Solution of Bupivacaine + Saline, SGB - Combined Solution of Bupivacaine + Ketamine Adjuvant - Posttraumatic Stress Disorder (PTSD) | Phase 2 | Not yet recruiting | The Royal's Institute of Mental Health Research | 126 | 2027-02-01 | 2026-11-16 |
| Psilocybin-Assisted Psychotherapy for Veterans With PTSD Psilocybin-assisted Psychotherapy - Posttraumatic Stress Disorder (PTSD) | Phase 2 | Not yet recruiting | ARQ National Psychotrauma Centre | 12 | 2026-12-01 | 2026-08-28 |
| MDMA-AT for PTSD in Young Adults With Childhood Trauma MDMA assisted psychotherapy - Posttraumatic Stress Disorder (PTSD) | Phase 2 | Not yet recruiting | Jenna M. Traynor | 15 | 2026-10-31 | 2026-08-20 |
| Post-traumatic Estradiol Administration and Care Evaluation (PEACE) 17β-estradiol, Placebo - Chronic Musculoskeletal Pain, Sexual Assault | Phase 2 | Not yet recruiting | University of North Carolina, Chapel Hill | 30 | 2026-09-28 | 2026-10-09 |
| The Many Roads to Trauma Recovery: A Clinical Trial Comparing Empirically Supported Treatments for Veterans With Co-Morbid Posttraumatic Stress and Substance Use Disorder Symptoms Trauma Informed Heart Rate Variability Biofeedback, Present Centered Therapy - Posttraumatic Stress Disorder (PTSD), Substance Use Disorder (SUD) | Phase 2 / Phase 3 | Recruiting | Coatesville VA Medical Center | 50 | 2026-08-01 | 2026-08-11 |
| Ketamine Assisted Psychotherapy for Treating Comorbid Chronic Pain and PTSD Ketamine Infusion, Mindfulness-based cognitive therapy - Chronic Pain, Posttraumatic Stress Disorder (PTSD) | Phase 1 / Phase 2 | Recruiting | Dr. Yuliya Knyahnytska | 30 | 2026-03-31 | 2026-09-15 |
| Ayahuasca, Esketamine and PTSD Ayahuasca, Esketamine - Posttraumatic Stress Disorder (PTSD) | Phase 2 | Recruiting | University of Sao Paulo | 10 | 2025-12-20 | 2026-01-05 |
| A Study to Evaluate Effects on Sleep and Safety of RE03 in PTSD Patients With Sleep Disturbances RE03, Placebo - Posttraumatic Stress Disorder (PTSD), Sleep Disturbances and Insomnia | Phase 2 | Completed | Reconnect Labs | 12 | 2025-09-30 | 2026-07-23 |
| High-Intensity Inpatient MDMA-Assisted Psychotherapy for PTSD High-intensity inpatient MDMA-assisted psychotherapy - Posttraumatic Stress Disorder (PTSD) | Phase 2 | Enrolling by invitation | ARQ National Psychotrauma Centre | 20 | 2025-05-16 | 2025-07-24 |
| NAC for Treating Comorbid PTSD and SUD N-acetylcysteine, Placebo, Cognitive behavioral therapy - Posttraumatic Stress Disorder (PTSD), Alcohol Use Disorder (AUD) | Phase 2 | Completed | Medical University of South Carolina | 90 | 2016-10-01 | 2021-05-19 |
| Oxytocin and Affect Processing in Posttraumatic Stress Disorder Oxytocin, Placebo - Posttraumatic Stress Disorder (PTSD) | Phase 2 | Completed | Yale University | 11 | 2015-08-01 | 2020-04-08 |
| Ketamine as a Treatment for Post-Traumatic Stress Disorder (PTSD) Ketamine, Midazolam - Posttraumatic Stress Disorder (PTSD) | Phase 2 / Phase 3 | Completed | Icahn School of Medicine at Mount Sinai | 30 | 2015-05-18 | 2021-03-11 |
| Prazosin and Naltrexone (PaN) Study for Veterans With Alcohol Use Disorders Prazosin, Naltrexone, Placebo (Prazosin) - Alcohol Use Disorder, Posttraumatic Stress Disorder (PTSD) | Phase 2 | Completed | Seattle Institute for Biomedical and Clinical Research | 31 | 2015-03-03 | 2020-12-29 |
| Randomized, Double-blind, Placebo-Controlled Pilot Study of MDMA-assisted Therapy for PTSD Active Placebo Dose MDMA-assisted therapy (25 mg), Full Dose MDMA-assisted therapy (125 mg), Open-Label Full Dose MDMA-assisted therapy (125 mg) - Posttraumatic Stress Disorder (PTSD) | Phase 2 | Completed | Resilient Pharmaceuticals | 10 | 2013-01-17 | 2025-06-06 |
| DElivery of Self Training and Education for Stressful Situations-Primary Care Version DESTRESS-PC, Optimized Usual Primary Care PTSD treatment - Posttraumatic Stress Disorder (PTSD) | Phase 2 | Completed | Henry M. Jackson Foundation for the Advancement of Military Medicine | 133 | 2008-05-01 | 2012-01-12 |
Stress Disorders, Post-Traumatic (15) · Substance-Related Disorders (3) · Wounds and Injuries (3) · Alcoholism (2) · Chronic Pain (2) · Alcohol Drinking (1) · Behavior, Addictive (1) · Drinking Behavior (1) · Parasomnias (1) · Sleep Initiation and Maintenance Disorders (1)
Mental Disorders (15) · Stress Disorders, Traumatic (15) · Trauma and Stressor Related Disorders (15) · Chemically-Induced Disorders (3) · Alcohol-Related Disorders (2) · Neurologic Manifestations (2) · Pain (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Behavior (1) · Compulsive Behavior (1) · Dyssomnias (1) · Impulsive Behavior (1) · Nervous System Diseases (1) · Sleep Disorders, Intrinsic (1)
Sodium Chloride (2) · Acetylcysteine (1) · Bupivacaine (1) · Cognitive Behavioral Therapy (1) · Esketamine (1) · Estradiol (1) · Ketamine (1) · Midazolam (1) · Mindfulness-Based Cognitive Therapy (1) · N-Methyl-3,4-methylenedioxyamphetamine (1) · Naltrexone (1) · Oxytocin (1) · Prazosin (1) · Psychotherapy (1)
ARQ National Psychotrauma Centre (2) · Coatesville VA Medical Center (1) · Dr. Yuliya Knyahnytska (1) · Henry M. Jackson Foundation for the Advancement of Military Medicine (1) · Icahn School of Medicine at Mount Sinai (1) · Jenna M. Traynor (1) · Medical University of South Carolina (1) · Reconnect Labs (1) · Resilient Pharmaceuticals (1) · Seattle Institute for Biomedical and Clinical Research (1) · The Royal's Institute of Mental Health Research (1) · University of North Carolina, Chapel Hill (1) · University of Sao Paulo (1) · Yale University (1)
United States (7) · Canada (2) · Netherlands (2) · Brazil (1) · Israel (1) · Switzerland (1)
Adriana Feder, MD (1) · Andres Ort, MD (1) · Charles C. Engel, M.D., M.P.H. (1) · Eric Vermetten, MD, PhD (1) · Jenna M Traynor (1) · Jennifer Tang, MD, MSCR (1) · Linda Mayes, MD (1) · Moshe Kotler (1) · Rebecca J Gomez, MD (1) · Sarah Linnstaedt, PhD (1) · Sudie Back, Ph.D. (1) · Tracy Simpson, Ph.D. (1)
PMID 31572236, PMID 29441152, PMID 30013726, PMID 31065731, PMID 32500209, PMID 33397139, PMID 33972795, PMID 34015141, PMID 37709999
2025 (1), R34MH078874 (1)